[Forschungsbericht]Der Markt für Gewebeverarbeitungssysteme wird bis 2027 voraussichtlich 493,76 Millionen US-Dollar erreichen, gegenüber 335,78 Millionen US-Dollar im Jahr 2019; Es wird geschätzt, dass der Markt von 2020 bis 2027 mit einer durchschnittlichen jährlichen Wachstumsrate von 5,1 % wächst.
Die Gewebeverarbeitung ist ein Schritt zwischen Gewebefixierung und -einbettung und dem Schneiden von Paraffinblöcken. Die Technik wird bei der Vorbereitung von Geweben für die mikroskopische Analyse eingesetzt, indem sie in ein festes Medium gegeben werden. Die Gewebeverarbeitung trägt dazu bei, sehr dünne und qualitativ hochwertige Schnitte zu liefern, die auf Objektträgern montiert und richtig gefärbt werden, um normale und abnormale Strukturen anzuzeigen. Das Wachstum des globalen Marktes für Gewebeverarbeitungssysteme wird hauptsächlich auf Faktoren wie die zunehmende Prävalenz von Krebs und die steigende Zahl diagnostischer Diagnosen zurückgeführt Labore. Allerdings schränken die hohen Kosten der Krebsdiagnose das Marktwachstum ein.
Lukrative regionale Märkte für Gewebeverarbeitungssysteme
Markteinblicke
Steigende Krebsprävalenz
Gewebeverarbeitungssysteme werden häufig in Krebsdiagnoselabors eingesetzt. Biopsieproben werden in Gewebeprozessoren zur Krebsdiagnose verarbeitet. Gewebeprozessoren sind seit den 1940er Jahren weit verbreitet und einfach zu bedienen und zu handhaben. Sie können eine große Anzahl von Proben verwalten, die Proben schnell verarbeiten und qualitativ hochwertige Ergebnisse liefern.
Laut der Weltgesundheitsorganisation (WHO) ist Krebs die zweithäufigste Todesursache weltweit; Im Jahr 2018 verursachte die Krankheit weltweit 9,6 Millionen Todesfälle. Darüber hinaus ist weltweit etwa jeder sechste Todesfall auf Krebs zurückzuführen. Der Anstieg der Zahl der Krebsfälle in Europa und die fortschrittliche diagnostische Infrastruktur in Europa dürften das Wachstum des Marktes in Europa begünstigen. Beispielsweise veröffentlichte die Gemeinsame Forschungsstelle im Juli 2020 Schätzungen zur Krebsprävalenz in der Europäischen Union für das Jahr 2020. Sie schätzte, dass die Krebslast im Jahr 2020 auf 2,7 Millionen Neuerkrankungen und 1,3 Millionen Todesfälle anstieg.
Damit steigt die Prävalenz Krebserkrankungen steigern die Nachfrage nach Gewebeprozessoren in der Diagnose.
Produktbasierte Einblicke
Der Markt für Gewebeverarbeitungssysteme ist nach Produkt in Gewebetransferprozessoren und Flüssigkeitstransferprozessoren unterteilt. Das Segment der Flüssigkeitstransferprozessoren hielt 2019 einen größeren Marktanteil, während das Segment der Gewebetransferprozessoren im Prognosezeitraum voraussichtlich eine höhere CAGR auf dem Markt verzeichnen wird. Gewebetransferprozessoren bieten Flexibilität bei der Verwendung von Reagenzien und ermöglichen Benutzern die Ausführung unterschiedlicher Zeitpläne.
Markt für Gewebeverarbeitungssysteme nach Produkt 2019 und 2027
Volumenbasierte Erkenntnisse
Der Markt für Gewebeverarbeitungssysteme ist nach Volumen in kleine Mengen unterteilt Prozessoren, Prozessoren mittlerer Lautstärke und Prozessoren großer Lautstärke. Das Segment der Prozessoren für kleine Volumina hielt 2019 den größten Marktanteil, und das Segment der Prozessoren für mittlere Volumina wird im Prognosezeitraum voraussichtlich die höchste CAGR verzeichnen.
Endbenutzerbasierte Erkenntnisse
< p>Basierend auf dem Endbenutzer ist der Markt für Gewebeverarbeitungssysteme in Krankenhäuser, Pharmaunternehmen, Forschungslabore und andere unterteilt. Das Krankenhaussegment hielt 2019 den größten Marktanteil, während das Segment der Pharmaunternehmen im Prognosezeitraum schätzungsweise die höchste CAGR von 5,7 % verzeichnen wird.
Strategische Einblicke
Produkt Markteinführungen und Zulassungen sind die von Unternehmen häufig angewandten Strategien zur Erweiterung ihrer globalen Präsenz und ihres Produktportfolios. Zusammenarbeit ist eine der wichtigsten Strategien der Marktteilnehmer für Gewebeverarbeitungssysteme, um den Kundenstamm weltweit zu vergrößern, was ihnen auch ermöglicht, ihren Markennamen weltweit aufrechtzuerhalten.
Markt für Gewebeverarbeitungssysteme nach Produkt
- Gewebetransferprozessoren
- Flüssigkeitstransferprozessoren
Markt für Gewebeverarbeitungssysteme nach Volumen
- Kleinserienprozessoren
- Prozessoren für mittlere Volumina
- Prozessoren für große Volumina
Markt für Gewebeverarbeitungssysteme nach Endbenutzern
- Krankenhäuser
- Pharmazeutische Unternehmen
- Forschungslabore
- Andere
Markt für Gewebeverarbeitungssysteme nach Geografie
- Nordamerika
- USA
- Kanada
- Mexiko
- Europa
- Frankreich
- Deutschland
- Italien
- Großbritannien
- Spanien
- Restliches Europa
- Asien-Pazifik (APAC)
- China
- Indien
- Südkorea
- Japan
- Australien
- Übriger Asien-Pazifik-Raum
- Naher Osten und Afrika (MEA)
- Südafrika
< li>Saudi-Arabien - VAE
- Rest von MEA
- Brasilien
- Argentinien
- Rest von Süd- und Mittelamerika
Unternehmensprofile
- MiltenyiBiotec
- BioGenex
- Leica Biosystems Nussloch GmbH (Danaher)
- Avantor, Inc.
- THERMO FISHER SCIENTIFIC INC.
- Siemens AG
- F. HOFFMANN-LA ROCHE LTD.
- Agilent Technologies, Inc.
- Milestone Medical
- Sakura Finetek USA, Inc.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Tissue processing occurs between tissue fixation and the embedding as well as the sectioning of the paraffin blocks. Tissue processing is used in the preparation of the tissue for microscopic analysis by putting the tissue in a solid medium. Tissue processing helps to provide very thin and high-quality slices mounted on the glass slides and properly stained to indicate normal and abnormal structures.
The factors that are driving growth of the market are increasing prevalence of cancer and rising number of diagnostic laboratories are factors driving the market growth. However, high cost of cancer diagnosis may hinder the market growth.
The tissue processing systems market majorly consists of the players such as Agilent Technologies, Inc., Biogenex Laboratories, Sakura Finetek Usa, Inc., Thermo Fisher Scientific Inc., Roche Diagnostics, Siemens Ag, Avantor, Milestone Medical, Leica Biosystems (Danaher Corporation), Miltenyi Biotec amongst others.
The List of Companies - Tissue Processing Systems Market
- Agilent Technologies Inc.
- Biogenex Laboratories
- Sakura Finetek Usa Inc.
- Thermo Fisher Scientific Inc.
- F. Hoffmann-La Roche AG
- Siemens Ag
- Avantor
- Milestone Medical
- Leica Biosystems (Danaher Corporation)
- Miltenyi Biotec
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Dec 2020
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Dec 2020
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Dec 2020
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Dec 2020
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Dec 2020
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Dec 2020
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Dec 2020
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)